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The Role of Robotic Surgery for Rectal Cancer: Overcoming 
Technical Challenges in Laparoscopic Surgery by Advanced 
Techniques
The conventional laparoscopic approach to rectal surgery has several limitations, and 
therefore many colorectal surgeons have great expectations for the robotic surgical system 
as an alternative modality in overcoming challenges of laparoscopic surgery and thus 
enhancing oncologic and functional outcomes. This review explores the possibility of 
robotic surgery as an alternative approach in laparoscopic surgery for rectal cancer. The da 
Vinci® Surgical System was developed specifically to compensate for the technical 
limitations of laparoscopic instruments in rectal surgery. The robotic rectal surgery is 
associated with comparable or better oncologic and pathologic outcomes, as well as low 
morbidity and mortality. The robotic surgery is generally easier to learn than laparoscopic 
surgery, improving the probability of autonomic nerve preservation and genitourinary 
function recovery. Furthermore, in very complex procedures such as intersphincteric 
dissections and transabdominal transections of the levator muscle, the robotic approach is 
associated with increased performance and safety compared to laparoscopic surgery. The 
robotic surgery for rectal cancer is an advanced technique that may resolve the issues 
associated with laparoscopic surgery. However, high cost of robotic surgery must be 
addressed before it can become the new standard treatment.
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INTRODUCTION
Rectal cancer surgery can be a very difficult procedure and in­
volves attempting to radically excise the cancer without damag­
ing the surrounding tissue. For this reason, functional and on­
cologic outcomes are not always favorable. However, after de­
velopment of total mesorectal excision (TME), functional out­
comes and the rate of local recurrences have improved remark­
ably (1). 
 Neoadjuvant chemoradiation therapy for rectal cancer increa­
ses resectability, allowing for performance of sphincter­saving 
curative resections, decreasing the locoregional recurrence rate, 
and improving survival rate. This modality has become com­
mon in most countries, according to National Comprehensive 
Cancer Network (NCCN) guideline (2­4).
 Several randomized controlled trials and reviews confirmed 
that laparoscopic colorectal resection results in improved early 
postoperative outcomes including reduction in intraoperative 
blood loss, postoperative pain, ileus and duration of hospital 
stay (5). Large randomized trials such as the CLASICC trial and 
the COREAN trial found minimally invasive approaches to be 
feasible and oncologically safe (6, 7). However, some random­
ized trials that evaluated long­term clinical outcomes of rectal 
cancer did not observe an increase in overall survival or in dis­
ease­free survival in patients who underwent laparoscopic­as­
sisted treatment (8­10). In addition, a previous study suggested 
that laparoscopic­assisted rectal surgery should not be used rou­
tinely because circumferential resection margin (CRM) positiv­
ity was higher in the laparoscopic group than in the open sur­
gery group (6).
 Unplanned intraoperative conversions from laparoscopic to 
open surgery indicate issues with the safety and feasibility of 
laparoscopic methods (6, 11). However, in Asian countries, many 
surgeons showed the conversion rate less than 5%. Kim et al. 
(12) reported that only two of 170 patients (1.2%) who underwent 
laparoscopic surgery were converted to open surgery. However, 
those results have some limitations because the laparoscopic 
surgery was performed by highly skilled laparoscopic special­
ists, and the study was performed in patients with limited on­
cologic risk due to the exclusion of cT4 lesions and focus on pa­
tients with a relatively low BMI. Kwak et al. (13) reported that 
two of 59 laparoscopic surgeries for rectal cancer were convert­
ed to open surgery (2/59, 3.4%). Even though the conversion 
rate was relatively low, they acknowledged that laparoscopic 
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fine pelvic dissection is very difficult and can cause bleeding 
from the lateral pelvic wall, rectal perforations, and unintended 
injury to adjacent organs. 
 Laparoscopic surgery has been used for more than 20 yr in 
the field of rectal cancer surgery, but there has been no signifi­
cant improvement in the postoperative complication rate over 
time. This may be due to the inherently high morbidity associat­
ed with rectal surgery or to limitations of current laparoscopic 
instruments (14). The conventional laparoscopic approach is 
particularly difficult because it involves unarticulated rigid in­
struments, an assistant­dependent, unstable, two­dimensional 
view, and poor ergonomics. In addition, surgical outcomes can 
be negatively impacted if the surgeon performing the surgery 
experiences tremors or is unable to perform high­precision su­
turing. These limitations are particularly remarkable during rec­
tal dissection in the pelvis as they result in poor nerve visualiza­
tion, traction injury, rectal cross stapling, difficult retraction, and 
crowding of the instruments. Because the pelvis is a relatively 
confined space, the operative view can be obscured by conden­
sation, which often results in fogging of the camera that can slow 
the progress of an already technically­demanding procedure (5).
 Since the first prospective randomized trial comparing robo­
tic low anterior resection and laparoscopic low anterior resec­
tion was launched by Baik et al. in 2006, several meta­analyses 
have been published on this technique, indicating a marked in­
terest in robotic surgery for rectal cancer. The studies demon­
strated the feasibility and safety of robotic low anterior resec­
tion and reported a better mesorectal grade in the robotic low 
anterior resection group (15­17).
 This review aims to explore the possibility of robotic surgery 
as a new standard treatment to overcome challenges associated 
with laparoscopic surgery for rectal cancer.
LITERATURE SEARCH
A literature search of electronic databases was performed using 
the terms ‘robot,’ ‘laparoscopic,’ ‘rectal surgery,’ ‘colonic surgery,’ 
‘total mesorectal excision’ and ‘proctectomy.’ Reference lists 
from papers identified in the first literature search were then 
reviewed for additional articles. Original articles, review articles 
and two case reports were included; all articles were published 
in English. Data from these studies are critically analyzed and 
summarized in this paper.
ROBOTIC SURGERY OF RECTAL CANCER
What are the potential benefits of the robotic system in 
rectal cancer surgery?
Limitations of current laparoscopic rectal surgery 
There is some concern about the higher rate of circumferential 
resection margin (CRM) involvement among rectal cancer pa­
tients undergoing low anterior resection with laparoscopic sur­
gery (12.4%) compared to that of open surgery (6.3%) in the 
CLASICC trial. In addition, the rectal laparoscopic subgroup 
had a higher conversion rate than the colon laparoscopic sub­
group (34% vs. 25%). Furthermore, in the CLASICC trial, mor­
tality and morbidity rates were highest in colon and rectal can­
cer patients who were converted from laparoscopic to open sur­
gery. Patients who underwent conversion had a higher mortali­
ty rate than open or laparoscopic patients (9% vs. 5% and 1%, 
respectively, P = 0.34). The complication rate was also higher in 
converted patients compared to non­converted patients and 
patients who underwent open surgery (P = 0.002). This suggests 
that there are still technical issues that need to be addressed for 
the use of the laparoscopic approach for rectal cancer (6, 18). In 
addition, the COLOR II trial reported non­inferior oncological 
outcomes but a high conversion rate (17%) in patients under­
going laparoscopic rectal surgery, although the conversion rate 
was decreased compared with previous studies. The study was 
a large multicentric randomized trial, but it was performed in 
selected patients treated by skilled surgeons (11).
Technical advantages and disadvantages of robotic surgery
The da Vinci® Surgical System was developed specifically to 
compensate for the technical limitations of laparoscopic instru­
ments. The system provides an ergonomic position, elimina­
tion of physiologic tremors, improved dexterity, seven degrees 
of freedom, motion scaling, stable camera, platform and stereo­
scopic views, and three­dimensional imaging (19). TME is the 
secure dissection of an avascular plane between the Waldeyer 
fascia and fascia propria or Denonvillier fascia and fascia pro­
pria without injuring the proper fascia of the rectum. Thus, the 
da Vinci surgical system is an excellent tool for performing TME 
in rectal cancer patients (20).
 However, the da Vinci system has some technical drawbacks. 
First, there is a lack of tactile sensation and tensile feedback to 
the surgeon. Consequently, tissue damage can occur easily dur­
ing traction by the robotic arm and during movement of the ro­
botic instrument. Moreover, suture material may be cut because 
there is no tensile feedback during suturing. Nevertheless, these 
technical disadvantages can be overcome by visual feedback, 
assuming the surgeon has sufficient experience (16). 
Comparable or improved oncologic outcomes of robotic surgery
In several non­randomized studies using participants from a 
single health center in Korea, robotic surgery for rectal cancer is 
associated with better oncologic outcomes. Baik et al. (21) re­
ported that the three­year overall survival and three­year dis­
ease­free survival rates in patients who underwent robotic rec­
tal surgery were 93.1% and 79.2%, respectively. In the present 
study, the CRM involvement rate, which represents a negative 
impact on oncologic outcomes, was 5.7%, and the three­year 
Park S, et al. • Role of Robotic Surgery for Rectal Cancer
http://jkms.org  839http://dx.doi.org/10.3346/jkms.2015.30.7.837
cumulative incidence of local recurrence was 3.6%. These re­
sults are similar to previous studies that evaluated the oncologic 
outcomes of conventional laparoscopic surgery for rectal can­
cer (22). Besides, there are some studies showing totally nega­
tive circumferential resection margin which lead to favorable 
oncologic outcomes. The authors in these studies claim that the 
negative resection margin rate may reflect better visualization 
and ergonomics with robotic technology (23, 24). In a multi­
centric study of robotic TME by Pigazzi et al. (25), remarkable 
short­term clinical outcomes were identified. The three­year 
overall survival rate was 97% in 143 consecutive patients with 
rectal cancer who underwent robotic surgery, and no isolated 
local recurrence was found during the mean follow­up period 
of 17.4 months. This study did not have a control group, had a 
relatively short follow­up period, and involved the extensive 
use of neoadjuvant chemoradiation. However, the results indi­
cate that robotic surgery improves survival rate and patient qual­
ity of life (Table 1).
Robotic-assisted rectal surgery may be a good treatment 
option in the future 
Totally robotic rectal surgery-single docking technique
We briefly describe the procedure of totally robotic rectal sur­
gery with a single­docking technique as performed in our insti­
tution. Totally robotic rectal surgeries using the da Vinci Surgi­
cal System consist of two phases: the lateral phase and the pel­
vic phase. During all processes, the robotic surgical cart is fixed, 
and the patient’s position does not change. The robotic surgical 
cart is located at the left caudal side of the surgical table. An as­
sistant stands at the patient’s right side in order to avoid mirror 
imaging during the operation. We used a six­port system includ­
ing a camera port to perform rectal cancer surgery from the sple­
nic flexure to the pelvic diaphragm without any change in the 
initial setup. Of the five working ports, one is used for dissec­
tion, another is used for traction and a third is used for the sur­
geon’s non­dominant hand. The remaining ports are used for 
the assistant’s hand or application of the endolinear stapler at 
the end of the pelvic phase (Fig. 1). 
 The procedure during the lateral phase includes medial to 
lateral dissection from the sacral promontory to the splenic flex­
ure along the avascular plane, dissection of tissue­bearing lymph 
nodes around the root of the inferior mesenteric artery, ligation 
and division of the inferior mesenteric artery, and splenic flex­
ure mobilization if needed. Procedures during the pelvic phase 
include dissection of the pelvic cavity along the plane between 
the mesorectal fascia proper and the parietal pelvic fascia pre­
serving the pelvic autonomic nerve plexus, division of the me­
sorectum if needed, and division of the rectum with the endolin­
ear stapler. Finally, anastomosis is performed laparoscopically 
or under direct vision after removal of the specimen through the 
Pfannelstiel skin incision made by extension of the port site (26). 
Improved performance and safety for intracorporeal suturing
Stefanidis et al. (27) showed that robotic assistance led to im­
proved suturing performance by novice surgeons, limited the 
number of inadvertent injuries to structures outside the operat­
ing field, and decreased operator workload in a live animal mo­
del. They also showed a shorter learning curve for intracorpo­
real suturing with robotic assistance compared with laparosco­
py. Suturing and knot­tying with robotic assistance were easier 
as evidenced by the higher participant performance scores, im­
proved ability to complete the task within the allowed time, and 
rapid improvement in score from the first to third attempt. An­
other study comparing robotic suture technique to laparoscop­
ic suture techniq ue showed that the advantage about intracor­
poreal suturing in robot was presented not only in novice group 
but also in expert group. This result means that robotic device is 
feasible regardless of amount of laparoscopic experience (28). 
The intracorporeal suture technique could allow for greater tech­
nical performance and accuracy in delicate operative fields. Dur­
ing an operation, surgeons sometime encounter unwanted events, 
such as bowel injury and bleeding, and robotic suturing could 
help surgeons to resolve these difficult situations, especially in 
narrow spaces. Additionally, the improved performance and 
accuracy afforded by robotic instruments allows surgeons to 
get closer to a natural orifice transluminal endoscopic surgery. 
Previously, Park et al. reported on the usefulness of a hybrid 
technique that eliminated the need for mini­laparotomy for re­
Table 1. Oncologic outcomes of robotic surgery
Study Operation type Survival Recurrence CRM involvement
Baik et al., 2013 (21) Robot 3 yr DFS: 79.2%
3 yr OS: 93.1%
3 yr incidence of local/systemic recurrence: 3.6%/17.6% 21/370 (5.7%)
Baik et al., 2011 (22) Laparoscopy 5 yr DFS: 88.5%
5 yr OS: 90.8%
5 yr incidence of local/systemic recurrence: 2.0%/11.1% 1/54 (1.9%)
D’Annibale et al., 2012 (23) Robot NA NA 0/50
Baek et al., 2010 (24) Robot 3 yr DFS: 73.7%
3 yr OS: 96.2%
*Total recurrence at mean f/u of 20.2 months: 6/64 (0.09%) 0/64
Pigazzi et al., 2010 (25) Robot 3 yr DFS: 77.6%
3 yr OS: 97%
Total recurrence at mean f/u of 17.4 months: 13/143 (0.09%) 1/143 (0.7%)
*Percentage of total recurrence counts during entire F/U period. DFS, disease free survival; OS, overall survival; CRM, circumferential resection margin.
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moval a specimen through the anus or vagina after complete 
intracorporeal resection and anastomosis in the rectal cancer 
using robotic intracorporeal suture (29, 30). This study showed 
not only how easy a surgeon manipulated the robotic devices 
but also how accurate movement of the robotic device was dur­
ing an operation.
Robotics to reduce conversion rate
A meta­analysis undertaken by Memon et al. (31) included sev­
en refined review articles and analyzed a total of 353 robot­as­
sisted laparoscopic proctectomies and 401 conventional lapa­
roscopic proctectomies. The overall conversion rate was higher 
for laparoscopic surgery compared to robotic surgery in all stud­
ies (total risk difference:­0.07 (95%CI, ­0.12 ~ ­0.01), Heteroge­
neity, I² = 80%, P = 0.03), and overall operation time was not 
significantly different (total risk difference, 2.96 [95%CI, ­0.12 ~ 
­0.01], Heterogeneity, I² = 95%, P = 0.19). Scarpinata et al. (32) 
reported that the conversion rate in robotic rectal surgery (1% 
to 7.3%) was lower than in laparoscopic rectal surgery (3% to 
22%), and the author claimed that the robotic approach was 
more optimal in difficult cases such as previous abdominal sur­
gery, lower rectal cancers, lower rectal cancers and previous 
chemoradiation therapy.
 Baek et al. (33) performed a retrospective study comparing 
short­term and long­term outcomes between robotic and lapa­
roscopic ultralow anterior resection with or without coloanal 
anastomosis. They showed that robotic surgery is a safe and fea­
sible approach with a lower conversion rate, a shorter hospital 
stay and similar oncologic outcomes compared with laparosco­
pic surgery. As previously mentioned, conversions have been 
associated suboptimal outcomes in terms of morbidity and mor­
tality. Therefore, a relatively low conversion rate in robotic rec­
tal surgery may indicate favorable long­term clinical outcomes.
Learning curve
In a study analyzed a learning curve in laparoscopic surgery us­
ing the moving average method for operative time, they showed 
that the surgeon typically became proficient in laparoscopic low 
anterior resection for rectal cancer after 50 cases. This was simi­
lar to previous studies, in which the learning curve for laparo­
Figure 1
Fig. 1. Placement of ports for totally robotic rectal surgery.
Robotic cart
Robotic cart
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scopic colectomy ranged from 30 to 70 cases (34).
 In some studies focused on the learning curve for robotic rec­
tal surgery, operative time and console time decreased remark­
ably after about 20 cases. The three­dimensional view and the 
ability of the robot to transfer the surgeon’s hand movements to 
the tips of the surgical instruments might greatly decrease the 
learning curve of robotic surgery compared to that of laparosco­
pic colorectal surgery. In addition, the technical advantages de­
scribed above enable inexperienced laparoscopic surgeons to 
operate the robot safely and easily (5, 35­37). However, recent 
studies of a large number of patients, in which multiple meth­
ods for evaluating learning curves were analyzed, have shown 
different results. The studies used not only operative time but 
also surgical outcomes related to risk factors as a tool for evalu­
ating learning curves. Among the results of a multidimensional 
analysis, studies have shown that there is multiphasic learning 
curve and initial learning period up to 32­44 cases (38­40). In 
these studies, the reason why the learning curve of robotic rec­
tal surgery is not shorter than conventional laparoscopic sur­
gery, despite easy manipulation of the robotic console, was ab­
sence of haptic sensation. If this drawback is overcome, the learn­
ing curve is expected to be shortened due to the technical ad­
vantages described above. Additionally, the reason why the learn­
ing curve consisted of two peaks and three phases was that tech­
nical competence to reduce an operative time was achieved in 
the initial phase. Surgical completion to overcome difficult cas­
es, such as lower tumor location and obese patients, or to reduce 
surgical failure was achieved in the second phase. Hereafter, a 
comparative analysis of learning curves between robot and lap­
aroscopy using a multidimensional analytic method is neces­
sary to demonstrate the advantages of robotic techniques.
Preservation of autonomic nerve system
Some studies have raised the concern that laparoscopic meso­
rectal excisions may be associated with urinary and sexual dys­
function, which is not typically an issue in conventional open 
surgery. Sexual function and behavior after laparoscopic total 
mesorectal excision were remarkably reduced compared to those 
before the operation or after open surgery (41­43).
 Three studies evaluating genitourinary function after robotic 
rectal surgery reported that postoperative sexual dysfunction 
improved one month after surgery and recovered gradually there­
after. Kim et al. reported that the robotic group showed earlier 
functional recovery than the laparoscopic group (Fig. 2), and 
D’Annibale et al. reported that erectile function was restored 
completely in the robotic group and partially restored in the 
laparoscopic group. All of the authors agreed that it was easier 
to identify the nerves and the planes of dissection using the ro­
Fig. 2. Changes in IIEF score and IPSS before surgery and several months after sur-
gery. IIEF, international index of erectile function; IPSS, international prostate symptom 
score; L/R-TME, laparoscopic/robot-assisted total mesorectal excision. Red circle, R-
TME allowed for an earlier recovery. Kim (43); Fab (44).
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Fig. 3. Preservation of autonomic nerve system related to genitourinary function (43).
Park S, et al. • Role of Robotic Surgery for Rectal Cancer
842  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.7.837
botic system (Fig. 3) (23, 44, 45). 
Anatomic deep pelvic dissection
Robotic pelvic lymph node dissection for locally advanced rectal 
cancer
Studies about lateral pelvic side­wall recurrence in advanced 
rectal cancer advocate that lateral pelvic lymph node dissection 
should be performed, because the overall incidence of metas­
tasis to lateral pelvic lymph nodes ranges from 8.6 to 27%. This 
result associates with positive nodes which are not cleared in 
patients who undergo TME only (46­48). One recent study sug­
gested that lateral pelvic side wall recurrence is a major cause of 
locoregional recurrence in patients treated with neoadjuvant 
chemoradiotherapy followed by TME (49). However, lateral pel­
vic lymph node dissection, in itself, can increase blood loss, uri­
nary and sexual dysfunction, and longer operation times with­
out survival benefits (47, 50, 51). Nonetheless, surgeons have 
demonstrated the feasibility and safety of a robotic approach 
for pelvic lymph node dissection for radical surgery, although 
these reports are outside the field of colorectal surgery (52, 53). 
If precise lymphovascular dissection with advanced robotic tech­
niques applies to locally advanced rectal cancer requiring pel­
vic lymph node dissection, then radical surgery can be perform­
ed more safely and more easily. 
Sphincter preservation and intersphincteric dissection
Intersphincteric dissection is one of the hardest forms of rectal 
surgical procedures. The procedure is associated with favorable 
long­term oncological and functional outcomes (54, 55). The 
technical advantages of robotic surgery, including accurate dis­
section and clear visibility, are particularly useful qualities dur­
ing pelvic dissection, especially because the cul de sac is very 
confined, and the pelvic structures adjacent to the rectum are 
easily injured (56). In addition, the robotic approach helps im­
prove intersphincteric dissection, which in turns decreases the 
duration of the perineal procedure. As a result, robotic intersph­
incteric dissection has led to several improved functional out­
comes (57). Further prospective randomized trials are needed 
to clarify the findings of recent studies about robotic intersphinc­
teric dissection.
Transabdominal division of the levator muscle
One study suggested new criteria to preserve the sphincter in 
ultra­low rectal cancer at the levator muscle level. Technically, 
the procedure is challenging, but with the endo­wrist advan­
tage of the robotic system, the abdominal phase becomes easi­
er. Also, perineal phase dissection can be simplified via an ap­
proach to the levator ani from the abdominal phase and divi­
sion at its origin. This method allows a preferred shallow shape 
of the levator ani plate, complicating the perineal phase due to 
the high location of the levator origin. This procedure preserv­
ing anus can be safe and feasible in the cases which were down­
sized after chemoradiation therapy (Fig. 4). However, long­term 
functional and oncological outcomes still need to be assessed 
after loop ileostomy reversal (58). 
 The lower rectum has a relatively thin mesorectal envelope 
because the mesorectum cones along the levator muscles end 
at the level of the puborectalis muscle. Poor visibility and inad­
equate surgical exposure in the deep pelvis as well as this ana­
tomical coning result in high circumferential margin (CRM) pos­
itivity of tumors within 5 cm of the anal verge. Abdominal peri­
neal resection (APR) can lead to higher CRM positivity than low 
anterior resection because it involves the blind perineal approach 
phase. CRM positivity is a predictive factor for local recurrence 
and disease­free survival (59). The extralevator approach to APR 
is associated with lower CRM positivity and incidence of rectal 
perforation, and as a result, the rate of local recurrence may de­
crease. However, approaching the levator muscles through the 
perineum remains difficult due to the blind approach. This can 
be overcome using robotic assistance to perform the transab­
dominal transection of levator muscles under direct visualiza­
tion (Fig. 5). Marecik et al. (60) reported excellent immediate 
postoperative and pathological results of robotic abdomino­
perineal resection with transabdominal levator transection in­
volving wide excision of the levator muscles, even though it was 
a small study with only five participants. An intact fascia propria 
and negative circumferential resection margin were achieved 
in all cases, and all specimens had a cylindrical shape.
Fig. 4. Multimodality treatment preserving anus: Neoadjuvant chemoradiation therapy 
and robotic rectal sleeve resection with colo-anal anastomosis (57).
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The use of indocyanine green fluorescence imaging 
methods in robotic surgery
Anastomotic leakage is a major life­threatening complication 
that can lead to frequent reoperations, multiple drainage pro­
cedures, and in rare cases, death. There are many factors asso­
ciated with anastomotic leakage including male gender, level of 
anastomosis (less than 5 cm), and preoperative radiation (61). 
Furthermore, perfusion abnormalities and technical factors 
which is caused by surgeons may become additional adverse 
factors (62). 
 Predictive tests for anastomotic leakage include active bleed­
ing from the resection margin, palpable pulsation in the mes­
entery and lack of discoloration. However, these measures are 
highly unreliable and fail to accurately predict postoperative 
leakage. (63). Indocyanine green (ICG) is a sterile, water­solu­
ble, tricarnocyanine compound that absorbs near infrared (NIR) 
light with a peak spectral absorption at 800 nm. When ICG is 
injected intravenously, it rapidly and extensively binds to plas­
ma protein and remains intravascular with minimal leakage 
into the interstitium. ICG fluorescene can be seen by the NIR 
camera system (64). Jafari et al. (65) showed that determination 
of resection point by ICG fluorescene during robot­assisted low 
anterior resection decreased anastomotic leakage. Kudszus et 
al. (66) used laser fluorescene angiography with ICG and a la­
ser­mounted scope to visualize the tissue perfusion and report­
ed a 60% reduction in reoperation for anastomotic leaks. ICG 
imaging can also be applied to vessel division and ligation with­
out adjacent tissue injury (67).
Cost effectiveness of robotic surgery
Cost is a major drawback of robotic rectal surgery. In a cost­com­
parison analysis between robotic rectal surgery and laparosco­
pic rectal surgery, Baek et al. (68) reported that robotic surgery 
is significantly more expensive than laparoscopic surgery for 
rectal cancer, with total hospital charges approximately 1.5 times 
higher in the robotic group compared to the laparoscopic group 
(13,644 USD vs. 9,065 USD, respectively; P < 0.001). Moreover, 
actual payments by patients were also significantly higher in 
the robotic group than the laparoscopic group, which the pay­
ment was almost three times as much in the robotic group com­
pared to the laparoscopic group (11,540 USD vs. 3,956 USD, re­
spectively; P < 0.001), but the total hospital charge and payment 
were decreasing according to accumulation of cases. In addi­
tion, hospital profit was significantly lower in the robotic group 
(689 USD vs. 1,671 USD respectively; P < 0.001) (Fig. 6). How­
ever, the authors pointed out that this was not a cost­effective­
ness study, but a cost­analysis study.
 For the popularization of robotic surgery, first of all, medical 
insurance cost should be adjusted and then patients sharing of 
the medical cost should be down. Second, in order to justify the 
high cost of robotic surgery, it must be shown that robotic sur­
gery is significantly better than other methods in terms of onco­
logic and functional outcomes, especially in difficult cases such 
as those involving preoperative chemoradiation therapy, obese 
patients, patients with a relatively narrow pelvis, or large tumors.
Fig. 5. The difference between conventional abdominoperineal resection and extrale-
vator abdominoperineal resection using robotic assistance.
Figure 5
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Extralevator abdominoperineal  
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   assistance
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Perineal approach Fig. 6. Changes of cost according to accumulation of cases in robotic surgery (67).
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CONCLUSION
In conclusion, robotic surgery for rectal cancer is a novel tech­
nique that has advanced the treatment of rectal cancer. Robotic 
surgery seems to address most of the shortcomings of laparo­
scopic surgery and is proven to be safe, easy to learn, and physi­
cal less taxing for surgeons. However, the high cost of robotic 
surgery is a major drawback. Robotic surgery may not become 
widespread until its obvious superiority over other methods is 
demonstrated in terms of oncologic and functional outcomes. 
 Presently, randomized trials to support robotic­assisted sur­
gery for rectal cancer such as the Robotic versus LAparoscopic 
Resection for Rectal cancer (ROLARR) trial and Comparison of 
Laparoscopic­Assisted vs. Robot­Assisted surgery for rectal can­
cer study Group (COLARAR) trial are ongoing to address this 
issue. We expect that the results from these trials will help es­
tablish the robotic approach as the new standard treatment in 
rectal cancer surgery. 
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